Medtronic plc stock edges lower as strong Q1 FY2027 figures meet cautious valuation
Published on 09/11/2026 at 14:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Medtronic plc stock (ISIN IE00BTN1Y115) is trading around USD 91 on the New York Stock Exchange as of September 10, 2026, leaving the medical technology group valued at more than USD 110 billion and still below its 12-month high near USD 106 according to data from MarketBeat and other portals.
Q1 FY2027 results give Medtronic plc stock fundamental support
For the current fiscal year 2027, Medtronic plc reported fiscal first-quarter 2027 revenue of nearly USD 9.8 billion, up 13.7 percent organically versus the prior-year quarter, providing a clear growth impulse for the business and a key backdrop for Medtronic plc stock, as highlighted by Yahoo Finance on September 10, 2026.
According to the same analysis, non-GAAP diluted EPS in fiscal Q1 2027 rose 15.1 percent to USD 1.45, underscoring that Medtronic converted the stronger top-line into faster earnings growth and delivered an EPS figure that exceeds many earlier consensus expectations from the previous year, which had centered around roughly USD 1.39 per share for comparable quarters as summarized by MarketBeat.
Analyst targets and valuation frame the investor view
On the analyst side, data compiled by MarketBeat show that Medtronic plc stock currently carries a consensus rating of Moderate Buy with an average price target of USD 103.92, implying upside of around 13 percent from the USD 91 to USD 92 price area as of September 10, 2026.
The same overview notes that Medtronic trades on a price-to-earnings ratio of about 22.7 based on recent earnings, a discount to a broader market multiple near 39 but not a deep-value level, which makes the combination of double-digit revenue growth and mid-teens EPS growth in fiscal Q1 2027 central to the medium-term case for Medtronic plc stock, according to MarketBeat.
Dividend and price levels add context for Medtronic plc stock
Income-oriented investors also pay attention to the dividend, with Medtronic having declared a quarterly cash dividend of USD 0.72 per share, corresponding to an annualized USD 2.88 and a yield just above 3 percent at a share price around USD 92, as documented by Stock Analysis, which lists an ex-dividend date of September 25, 2026.
From a price perspective, recent filings summarized by MarketBeat mention Medtronic plc stock opening at USD 91.60 on the New York Stock Exchange on September 11, 2026, with a 12-month low of USD 73.31 and a 12-month high of USD 106.33, placing the current level closer to the upper half of the range but still noticeably below the peak.
Medtronic plc stock price and key trading data
Per recent NYSE price data cited by portals such as Yahoo Finance, Medtronic plc stock closed at around USD 91.62 on September 10, 2026, down about 0.29 percent on the day, before trading nearly flat in after-hours transactions.
Medtronic plc stock key data
- Company: Medtronic plc
- ISIN: IE00BTN1Y115
- Ticker: MDT
- Trading venue: NYSE
- Price (as of September 10, 2026, 4:00): 91.62 USD
- Market capitalization: 117,170,000,000 USD (as of September 10, 2026)
- Sector / Industry: Health Care / Medical Devices
- Index membership: S&P 500
- Next earnings date: November 26, 2026
